Technical Analysis for CELC - Celcuity Inc.

Grade Last Price % Change Price Change
grade F 17.4 0.58% 0.10
CELC closed up 0.58 percent on Friday, September 13, 2019, on 2.3 times normal volume.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical CELC trend table...

Date Alert Name Type % Chg
Pocket Pivot Bullish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 1.99%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 2.35%
Narrow Range Bar Range Contraction 2.35%
NR7 Range Contraction 2.35%
Inside Day Range Contraction 2.35%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 1.75%
Inside Day Range Contraction 1.75%
Wide Bands Range Expansion 1.75%
20 DMA Resistance Bearish 2.72%

Older signals for CELC ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Celcuity, Inc. is a United States-based early stage biotechnology company. The Company develops tests that functionally analyze diseased live cells. The Company has developed CELx Pathway Profile technology, which combines advancements in primary tissue research with a method of measuring a targeted therapy's functional pathway effect on live and diseased patient cells. The Company offers functional cellular analysis platform that assesses the functionality of the disease-related signaling pathways of patient's diseased cells ex vivo and determines whether a drug therapy has the effect on diseased cells. The Company's CELx test is designed to determine whether a pathway is functional to therapeutic intervention without regard to the exact mechanism a patient's tumor may have developed to resist the therapeutic effect. The Company’s diagnostic approach helps to identify cancer subtypes.
Biotechnology Cancer Biology Stem Cells Cell Biology Cell Signaling Signal Transduction Drug Therapy Systems Biology Patient's Tumor
Is CELC a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 31.0
52 Week Low 15.54
Average Volume 6,921
200-Day Moving Average 21.7265
50-Day Moving Average 20.0628
20-Day Moving Average 17.5075
10-Day Moving Average 17.229
Average True Range 1.1141
ADX 17.19
+DI 17.1763
-DI 22.5802
Chandelier Exit (Long, 3 ATRs ) 17.5177
Chandelier Exit (Short, 3 ATRs ) 18.8823
Upper Bollinger Band 19.4899
Lower Bollinger Band 15.5251
Percent B (%b) 0.47
BandWidth 22.646294
MACD Line -0.7902
MACD Signal Line -0.9436
MACD Histogram 0.1534
Fundamentals Value
Market Cap 169.17 Million
Num Shares 9.72 Million
EPS -0.02
Price-to-Earnings (P/E) Ratio -870.00
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 18.68
Resistance 3 (R3) 18.57 18.03 18.47
Resistance 2 (R2) 18.03 17.70 18.09 18.40
Resistance 1 (R1) 17.72 17.50 17.45 17.83 18.33
Pivot Point 17.18 17.18 17.04 17.23 17.18
Support 1 (S1) 16.86 16.85 16.59 16.97 16.47
Support 2 (S2) 16.32 16.65 16.38 16.40
Support 3 (S3) 16.01 16.32 16.33
Support 4 (S4) 16.12